| UniProt ID | MDM4_HUMAN | |
|---|---|---|
| UniProt AC | O15151 | |
| Protein Name | Protein Mdm4 | |
| Gene Name | MDM4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 490 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Inhibits p53/TP53- and TP73/p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Inhibits degradation of MDM2. Can reverse MDM2-targeted degradation of TP53 while maintaining suppression of TP53 transactivation and apoptotic functions.. | |
| Protein Sequence | MTSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSRLDLGFEEWDVAGLPWWFLGNLRSNYTPRSNGSTDLQTNQDVGTAIVSDTTDDLWFLNESVSEQLGVGIKVEAADTEQTSEEVGKVSDKKVIEVGKNDDLEDSKSLSDDTDVEVTSEDEWQCTECKKFNSPSKRYCFRCWALRKDWYSDCSKLTHSLSTSDITAIPEKENEGNDVPDCRRTISAPVVRPKDAYIKKENSKLFDPCNSVEFLDLAHSSESQETISSMGEQLDNLSEQRTDTENMEDCQNLLKPCSLCEKRPRDGNIIHGRTGHLVTCFHCARRLKKAGASCPICKKEIQLVIKVFIA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 20 | Phosphorylation | SDSACRISPGQINQV CCCCCCCCCHHHCCC | 12.02 | 25159151 | |
| 55 | Phosphorylation | TVKEVMHYLGQYIMV EHHHHHHHHHHHHHH | 8.40 | 19075013 | |
| 93 | Ubiquitination | GRQSFSVKDPSPLYD CCCCCCCCCCCHHHH | 63.82 | - | |
| 96 | Phosphorylation | SFSVKDPSPLYDMLR CCCCCCCCHHHHHHH | 37.36 | 22817900 | |
| 99 | Phosphorylation | VKDPSPLYDMLRKNL CCCCCHHHHHHHHCC | 11.59 | 19075013 | |
| 108 | Phosphorylation | MLRKNLVTLATATTD HHHHCCCHHHHCCCC | 17.53 | 25332170 | |
| 113 | Phosphorylation | LVTLATATTDAAQTL CCHHHHCCCCHHHHH | 22.36 | 28348404 | |
| 114 | Phosphorylation | VTLATATTDAAQTLA CHHHHCCCCHHHHHH | 22.60 | 28348404 | |
| 119 | Phosphorylation | ATTDAAQTLALAQDH CCCCHHHHHHHHHHC | 14.85 | 27251275 | |
| 127 | Phosphorylation | LALAQDHSMDIPSQD HHHHHHCCCCCCCHH | 26.83 | 28348404 | |
| 150 | Phosphorylation | SSTSRKRTTEDDIPT HCCCCCCCCCCCCCC | 37.26 | 23186163 | |
| 151 | Phosphorylation | STSRKRTTEDDIPTL CCCCCCCCCCCCCCC | 41.26 | 23186163 | |
| 157 | Phosphorylation | TTEDDIPTLPTSEHK CCCCCCCCCCCCCCC | 45.78 | 23186163 | |
| 160 | Phosphorylation | DDIPTLPTSEHKCIH CCCCCCCCCCCCCCC | 50.27 | 28450419 | |
| 161 | Phosphorylation | DIPTLPTSEHKCIHS CCCCCCCCCCCCCCC | 35.45 | 28450419 | |
| 222 (in isoform 5) | Phosphorylation | - | 41.99 | 24114839 | |
| 254 | Sumoylation | EQLGVGIKVEAADTE HHHCCCEEEEECCCC | 28.26 | - | |
| 254 | Sumoylation | EQLGVGIKVEAADTE HHHCCCEEEEECCCC | 28.26 | - | |
| 263 | Phosphorylation | EAADTEQTSEEVGKV EECCCCCCHHHHHCC | 31.69 | - | |
| 264 | Phosphorylation | AADTEQTSEEVGKVS ECCCCCCHHHHHCCC | 31.30 | - | |
| 289 | Phosphorylation | DDLEDSKSLSDDTDV CCHHHHCCCCCCCCC | 36.74 | 22817900 | |
| 291 | Phosphorylation | LEDSKSLSDDTDVEV HHHHCCCCCCCCCEE | 40.30 | 27251275 | |
| 314 | Phosphorylation | TECKKFNSPSKRYCF CCCCCCCCCCCHHHH | 33.41 | 25849741 | |
| 316 | Phosphorylation | CKKFNSPSKRYCFRC CCCCCCCCCHHHHHH | 29.59 | 30576142 | |
| 328 | Ubiquitination | FRCWALRKDWYSDCS HHHHHHCCHHHHHHH | 54.16 | - | |
| 336 | Ubiquitination | DWYSDCSKLTHSLST HHHHHHHHHHHCCCH | 64.83 | - | |
| 338 | Phosphorylation | YSDCSKLTHSLSTSD HHHHHHHHHCCCHHC | 17.10 | 28464451 | |
| 340 | Phosphorylation | DCSKLTHSLSTSDIT HHHHHHHCCCHHCCC | 20.84 | 25159151 | |
| 342 | Phosphorylation | SKLTHSLSTSDITAI HHHHHCCCHHCCCCC | 28.96 | 23401153 | |
| 343 | Phosphorylation | KLTHSLSTSDITAIP HHHHCCCHHCCCCCC | 35.39 | 25159151 | |
| 344 | Phosphorylation | LTHSLSTSDITAIPE HHHCCCHHCCCCCCC | 24.52 | 25159151 | |
| 347 | Phosphorylation | SLSTSDITAIPEKEN CCCHHCCCCCCCCCC | 24.43 | 26552605 | |
| 365 | Phosphorylation | DVPDCRRTISAPVVR CCCCHHHHCCCCCCC | 10.42 | 15788536 | |
| 367 | Phosphorylation | PDCRRTISAPVVRPK CCHHHHCCCCCCCCH | 26.38 | 16163388 | |
| 374 | Ubiquitination | SAPVVRPKDAYIKKE CCCCCCCHHHCCCCC | 44.41 | - | |
| 379 | Sumoylation | RPKDAYIKKENSKLF CCHHHCCCCCCCCCC | 41.16 | - | |
| 379 | Sumoylation | RPKDAYIKKENSKLF CCHHHCCCCCCCCCC | 41.16 | - | |
| 384 | Ubiquitination | YIKKENSKLFDPCNS CCCCCCCCCCCCCCC | 65.83 | - | |
| 391 | Phosphorylation | KLFDPCNSVEFLDLA CCCCCCCCEEHHHCC | 29.73 | 16163388 | |
| 403 | Phosphorylation | DLAHSSESQETISSM HCCCCCCCHHHHHHH | 34.95 | 15788536 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 55 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
| 55 | Y | Phosphorylation | Kinase | ABL-FAMILY | - | GPS |
| 96 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 99 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
| 99 | Y | Phosphorylation | Kinase | ABL-FAMILY | - | GPS |
| 289 | S | Phosphorylation | Kinase | CSNK1A1 | P48729 | GPS |
| 314 | S | Phosphorylation | Kinase | CDK4 | P11802 | PSP |
| 314 | S | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
| 342 | S | Phosphorylation | Kinase | PRKAA1 | P54645 | GPS |
| 342 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
| 342 | S | Phosphorylation | Kinase | CHK2 | O96017 | PSP |
| 367 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
| 367 | S | Phosphorylation | Kinase | CHK1 | O14757 | PSP |
| 367 | S | Phosphorylation | Kinase | CHK2 | O96017 | PSP |
| 403 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | MDM2 | Q00987 | PMID:10218570 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MDM4_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "14-3-3gamma binds to MDMX that is phosphorylated by UV-activatedChk1, resulting in p53 activation."; Jin Y., Dai M.S., Lu S.Z., Xu Y., Luo Z., Zhao Y., Lu H.; EMBO J. 25:1207-1218(2006). Cited for: FUNCTION IN TP53 ACTIVATION, PHOSPHORYLATION AT SER-367 BY CHEK1, ANDINTERACTION WITH YWHAG. | |
| "ATM and Chk2-dependent phosphorylation of MDMX contribute to p53activation after DNA damage."; Chen L., Gilkes D.M., Pan Y., Lane W.S., Chen J.; EMBO J. 24:3411-3422(2005). Cited for: FUNCTION IN TP53 ACTIVATION, PHOSPHORYLATION AT SER-342 AND SER-367 BYCHEK2, UBIQUITINATION, AND INTERACTION WITH MDM2. | |